NextCure, Inc. (NXTC) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 32 transactions totaling $25.4M, demonstrating a bullish sentiment with $25.4M in net insider flow. The most recent transaction on Jul 14, 2020 involved a transaction of 27,229 shares valued at $48.2K.
No significant insider buying has been recorded for NXTC in the recent period.
No significant insider selling has been recorded for NXTC in the recent period.
Based on recent SEC filings, insider sentiment for NXTC is bullish with an Insider Alignment Score of 100/100 and a net flow of $25.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at NextCure, Inc. (NXTC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading NXTC stock, having executed 32 transactions in the past 90 days. The most active insider is Management Ix, L.l.c. Sofinnova (Executive), who has made 5 transactions totaling $6.0M.
Get notified when executives and directors at NXTC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 14, 2020 | N. Heller Kevin | Executive | Option Exercise | 27,229 | $1.77 | $48.2K | |
| Nov 27, 2019 | Liu Linda | Executive | Option Exercise | 20,745 | $1.21 | $25.1K | |
| Nov 27, 2019 | Liu Linda | Executive | Option Exercise | 34,489 | $0.48 | $16.6K | |
| Nov 15, 2019 | Partners Ix, L.p. Sofinnova Venture | Executive | Purchase | 150,000 | $36.75 | $5.5M | Large |
| May 13, 2019 | Gp VI Llc Orbimed Capital | Executive | Purchase | 350,000 | $15.00 | $5.3M | Large |
| May 13, 2019 | Gp VI Llc Orbimed Capital | Executive | Conversion | 442,438 | $N/A | $0 | |
| May 13, 2019 | Gp VI Llc Orbimed Capital | Executive | Conversion | 445,866 | $N/A | $0 | |
| May 13, 2019 | Gp VI Llc Orbimed Capital | Executive | Conversion | 743,110 | $N/A | $0 | |
| May 13, 2019 | Gp VI Llc Orbimed Capital | Executive | Conversion | 729,599 | $N/A | $0 | |
| May 13, 2019 | L.p. Canaan X. | Executive | Conversion | 743,110 | $N/A | $0 | |
| May 13, 2019 | L.p. Canaan X. | Executive | Conversion | 285,867 | $N/A | $0 | |
| May 13, 2019 | L.p. Canaan X. | Executive | Conversion | 729,599 | $N/A | $0 | |
| May 13, 2019 | L.p. Canaan X. | Executive | Conversion | 445,866 | $N/A | $0 | |
| May 13, 2019 | L.p. Canaan X. | Executive | Purchase | 50,000 | $15.00 | $750.0K | Large |
| May 13, 2019 | Xu Stella | Executive | Purchase | 125,000 | $15.00 | $1.9M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 7 | $25.4M | 99.6% |
Exercise(M) | 3 | $89.9K | 0.4% |
Conversion(C) | 22 | $0 | 0.0% |
Insiders at NextCure, Inc. are accumulating shares at an accelerated pace. With 10 insiders making 32 transactions totaling $25.4M in purchases versus $0 in sales, the net buying activity of $25.4M signals strong executive confidence. Management Ix, L.l.c. Sofinnova (Executive) leads the buying activity with $6.0M in transactions across all time.